tiprankstipranks
Trending News
More News >
ImmuPharma PLC (GB:IMM)
LSE:IMM

ImmuPharma (IMM) Revenue

Compare
21 Followers

ImmuPharma Revenue

ImmuPharma had a revenue of 0.00 in the quarter ending Jun 30, 2024, with ―. This bring the company's revenue in the last twelve months to -69.96K, Increased -6995900.00%. In the fiscal year ending Dec 31, 2023, ImmuPharma had annual revenue of 0.00 with ― growth.
Revenue (ttm)
-69.96K
Revenue Growth
P/S Ratio
Infinity
Revenue/Employee
£0
Employees
5
Market Cap
£10.67M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2023
0.00
Dec 31, 2022
0.00-118.35K-100.00%
Dec 31, 2021
118.35K-8.32K-6.57%
Dec 31, 2020
126.67K48.74K+62.55%
Dec 31, 2019
77.92K-3.36K-4.13%
Dec 31, 2018
81.28K-69.18K-45.98%
Dec 31, 2017
150.46K-14.32K-8.69%
Dec 31, 2016
164.78K
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis